The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
IntroductionWe have recently developed a novel T cell engager concept by utilizing γ9δ2TCR as tumor targeting domain, named gamma delta TCR anti-CD3 bispecific molecule (GAB), targeting the phosphoantigen-dependent orchestration of BTN2A1 and BTN3A1 at the surface of cancer cells. GABs are made by...
Main Authors: | Eline van Diest, Mara J. T. Nicolasen, Lovro Kramer, Jiali Zheng, Patricia Hernández-López, Dennis X. Beringer, Jürgen Kuball |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1052090/full |
Similar Items
-
Natural Self-Ligand Gamma Delta T Cell Receptors (γδTCRs) Insight: The Potential of Induced IgG
by: Thamires Rodrigues de Sousa, et al.
Published: (2020-08-01) -
Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
by: Scott A. Becker, et al.
Published: (2023-06-01) -
Human gamma delta T regulatory cells in cancer: fact or fiction?
by: Daniela eWesch, et al.
Published: (2014-11-01) -
Silent T-cell receptor cutaneous T-cell lymphoma associated to a clonal plasma cell proliferation
by: Ana Caballero, et al.
Published: (2019-02-01) -
Editorial: Next generation γδ T cell-based tumor immunotherapy
by: Andy Hee-Meng Tan, et al.
Published: (2022-09-01)